Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2

Journal: Journal of Biological Chemistry

Published: 2020-04-24

DOI: 10.1074/jbc.ra119.011685

Affiliations: 10

Authors: 18

Go to article
Institutions Share
Mayo Clinic Department of Orthopedic Surgery, United States of America (USA) 0.60
Amsterdam UMC, Netherlands 0.11
Mayo Clinic Department of Biochemistry and Molecular Biology, United States of America (USA) 0.08
Department of Developmental Bioengineering (DBE), UTwente, Netherlands 0.06
Mayo Clinic Graduate School of Biomedical Sciences, United States of America (USA) 0.03
Mayo Clinic Center for Regenerative Medicine, United States of America (USA) 0.03
Institute of Medical Biology (IMB), A*STAR, Singapore 0.03
NUS Department of Orthopaedic Surgery, Singapore 0.03
Second Affiliated Hospital of Zhejiang University (SAHZU), ZJU, China 0.02
Shanghai Tenth People's Hospital, Tongji University, China 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER